The Health Foundation, London, UK; College of Social Sciences, Health Services Management Centre, University of Birmingham, Birmingham, UK.
Department of Health Policy, London School of Economics and Political Science, London, UK.
Lancet. 2021 May 22;397(10288):2012-2022. doi: 10.1016/S0140-6736(21)00230-0. Epub 2021 May 6.
The health and care sector plays a valuable role in improving population health and societal wellbeing, protecting people from the financial consequences of illness, reducing health and income inequalities, and supporting economic growth. However, there is much debate regarding the appropriate level of funding for health and care in the UK. In this Health Policy paper, we look at the economic impact of the COVID-19 pandemic and historical spending in the UK and comparable countries, assess the role of private spending, and review spending projections to estimate future needs. Public spending on health has increased by 3·7% a year on average since the National Health Service (NHS) was founded in 1948 and, since then, has continued to assume a larger share of both the economy and government expenditure. In the decade before the ongoing pandemic started, the rate of growth of government spending for the health and care sector slowed. We argue that without average growth in public spending on health of at least 4% per year in real terms, there is a real risk of degradation of the NHS, reductions in coverage of benefits, increased inequalities, and increased reliance on private financing. A similar, if not higher, level of growth in public spending on social care is needed to provide high standards of care and decent terms and conditions for social care staff, alongside an immediate uplift in public spending to implement long-overdue reforms recommended by the Dilnot Commission to improve financial protection. COVID-19 has highlighted major issues in the capacity and resilience of the health and care system. We recommend an independent review to examine the precise amount of additional funds that are required to better equip the UK to withstand further acute shocks and major threats to health.
卫生保健部门在改善人口健康和社会福利、保护人们免受疾病带来的经济后果、减少健康和收入不平等以及支持经济增长方面发挥着宝贵的作用。然而,对于英国卫生保健的适当资金水平存在着很多争议。在这份卫生政策文件中,我们研究了 COVID-19 大流行的经济影响以及英国和可比国家的历史支出,评估了私人支出的作用,并审查了支出预测,以估算未来的需求。自 1948 年国家卫生服务体系(NHS)成立以来,公共卫生支出平均每年增长 3.7%,此后,它在经济和政府支出中所占的份额继续增加。在当前大流行开始前的十年里,卫生和保健部门政府支出的增长率有所放缓。我们认为,如果没有公共卫生支出每年实际增长至少 4%,那么 NHS 就有退化、福利覆盖范围缩小、不平等加剧以及更多依赖私人融资的风险。需要类似(如果不是更高)水平的公共社会保健支出,以提供高标准的保健和体面的社会保健工作人员待遇和工作条件,同时立即增加公共支出,以实施 Dilnot 委员会建议的长期拖欠的改革,以改善财务保障。COVID-19 凸显了卫生保健系统的能力和弹性方面的重大问题。我们建议进行一次独立审查,以确定需要多少额外资金来更好地装备英国,以抵御进一步的急性冲击和对健康的重大威胁。